"Pharmaceuticals or devices and diagnostics are two major revenue earners for any private hospital. Doctors point out that the huge MRP enables companies to attract hospitals with the prospect of high margins. Private hospitals are making a killing by buying medicines and devices in bulk at huge discounts and selling them to patients at the marked maximum retail price — accounting for 15-35% of their profits. Yet, the failure of governments to boost public health infrastructure in keeping with rising demand has pushed patients to the private sector. She was given an injection, Novartis's Zometa, that costs Rs 15,200 per shot, every three to four weeks for over two years in a top private hospital in Gurgaon.

Source: Times of India July 23, 2016 19:30 UTC